|
DRUG DESCRIPTION
Morphine sulphate Cas No. 64-31-3
Morphine can be abused in a manner similar to other opioid agonists, legal
or illicit. This should be considered when prescribing or dispensing
Morphine sulphate in situations where the physician or pharmacist is
concerned about an increased risk of misuse, abuse, or diversion.
Chemically, morphine sulfate is
7,8-didehydro-4,5α-epoxy-17-methylmorphinan-3,6α-diol sulfate (2:1) (salt)
pentahydrate
Morphine sulphate Tablets are opiate analgesics supplied in 15, 30, 60, 100
and 200 mg tablet strengths. The tablet strengths describe the amount of
morphine per tablet as the pentahydrated sulfate salt (morphine sulfate, USP).
Morphine sulphate Controlled-release Tablets 15 mg, 30 mg, 60 mg, 100 mg,
and 200 mg contain the following inactive ingredients: cetostearyl alcohol,
hydroxyethyl cellulose, hypromellose, magnesium stearate, polyethylene
glycol, talc and titanium dioxide.
Morphine sulphate Controlled-release Tablets 15 mg also contains FD&C Blue
No. 2, lactose and polysorbate 80.
Morphine sulphate Controlled-release Tablets 30 mg also contains D&C Red No.
7, FD&C Blue No. 1, lactose and polysorbate 80.
Morphine sulphate Controlled-release Tablets 60 mg also contains D&C Red No.
30, D&C Yellow No. 10, hydroxypropyl cellulose, and lactose.
Morphine sulphate Controlled-release Tablets 100 mg also contains black iron
oxide.
Morphine sulphate Controlled-release Tablets 200 mg also contains D&C Yellow
No. 10, FD&C Blue No. 1, and hydroxypropyl cellulose.
|